Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Medicare, Novo Nordisk A/S, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), United States Politics and Government
←Social Media Users Shut Down GOP Senator Over His Out-Of-Control Disasters Claim
Seth Meyers Wants Biden To Do 1 ‘Wicked’ Thing At Donald Trump’s Inauguration→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube